Which Price is Right: Load or Premium?

GENEVA Risk and Insurance Review - Tập 33 - Trang 90-105 - 2008
Rexford E Santerre1
1Department of Finance, Center for Healthcare & Insurance Studies, School of Business, University of Connecticut, Storrs, U.S.A.

Tóm tắt

This paper uses national time series data for the United States to investigate whether changes in the premium or loading fee offer a better explanation for variations in the percentage of the population with private health insurance from 1960 to 2004. The empirical results suggest that premium provides a better measure of price when estimating the demand for health insurance at the extensive margin. The empirical analysis also indicates that the aggregate short-run price and income elasticities of demand for health insurance are fairly close at −0.19 and 0.27, respectively. One implication is that the percentage of the population with private health insurance in the United States should continue to decline in the future if real premiums persistently grow significantly faster than the overall economy.

Tài liệu tham khảo

Chernew, M., Cutler, D.M. and Keenan, P.S. (2005) ‘Increasing health insurance costs and the decline in insurance coverage’, Health Services Research 40: 1021–1039. Davidson, R. and MacKinnon, J.G. (1993) Estimation and Inference in Econometrics, New York: Oxford University Press. DeNavas-Walt, C., Proctor, B.D. and Lee, C.H. (2005) Income, poverty, and health insurance coverage in the United States: 2004, U.S. Census Bureau, Current Population Reports, P60-229, U.S. G.P.O., Washington, DC. Feldstein, P.J. (1999) Health Care Economics, Albany, NY: Delmar Publishers. Gabel, J., Formisano, R., Lohr, B. and Di Carlo, S. (1991) ‘Tracing the cycle of health insurance’, Health Affairs 10 (winter): 49–61. GAO (1998) ‘Private health insurance: Impact of premium increases on the number of covered individuals is uncertain’, GAO/HEHS-98-203R. Gilmer, T. and Kronick, R. (2005) ‘It's the premiums, stupid: Projections of the uninsured through 2013’, Health Affairs Web Exclusive, 5 April, pp. w5-143–w5-151. Granger, C. and Newbold, P. (1974) ‘Spurious regressions in econometrics’, Journal of Econometrics 2: 111–120. Grossman, J.M. and Ginsburg, P.B. (2004) ‘As the health insurance underwriting cycle turns: What next?’, Health Affairs 23: 90–102. Hausman, J.A. (1978) ‘Specification tests in econometrics’, Econometrica 46: 1251–1271. Hay, J.W. and Leahy, M.J. (1987) ‘Competition among health plans: some preliminary evidence’, Southern Economic Journal 50: 831–846. Health Insurance Association of America (HIAA) (1999) Source Book of Health Insurance Data, Washington, DC.: HIAA. Johnson, H.M. (1965) ‘Major medical expense insurance’, Journal of Risk and Insurance 32: 211–236. Kennedy, P. (2003) A Guide to Econometrics, Cambridge, MA: The MIT Press. Lichtenberg, F. (2007) ‘Effects of new drugs on overall health spending: Frank Lichtenberg responds’, Health Affairs 26 (3): 887–890. MacIntyre, D.M. (1965) ‘Rate philosophy and health insurance competition’, Journal of Risk and Insurance 32: 525–537. Maddala, G.S. (1992) Introduction to Econometrics, New York: MacMillan Publishing Company. Miller, W., Vigdor, E.R. and Manning, W.G. (2004) ‘Covering the uninsured: what is it worth?’, Health Affairs Web Exclusive, 31 March, pp. 157–167. Nyman, J.A. (2003) The Theory of Demand for Health Insurance, Stanford, CA: Stanford University Press. Phelps, C.E. (1997) Health Economics, Reading, MA: Addison-Wesley. Phillips, P.C. (1986) ‘Understanding spurious relations in econometrics’, Journal of Econometrics 33: 311–340. Reed, L.S. (1967) ‘Private health insurance: Coverage and financial experience, 1940–1966’, Social Security Bulletin 30: 3–22. Santerre, R.E. and Neun, S.P. (2007) Health Economics: Theories, Insights, and Industry Studies, Mason, OH: South-Western Publishers. Sindelar, J.L. (1988) ‘The declining price of health insurance’, in H.E. Frech III (ed.) Health Care in America, San Francisco: Pacific Institute for Public Policy, pp. 259–291. Zhang, Y. and Soumerai, S.B. (2007) ‘Do newer prescription drugs pay for themselves? A reassessment of the evidence’, Health Affairs 26 (3): 880–886.